Global Medical Devices Industry Strategic Research Report

The global medical devices market reached $581.1 billion in 2025, derived as the average of four independently published market research estimates that converge tightly within a $572-586 billion range, a notably tighter convergence than found for the companion Healthcare-industry-strategic-research-report" title="Global Healthcare Industry Strategic Research Report">healthcare Industry report, reflecting medical devices being a more consistently-scoped market category across research firms. This report defines the medical devices industry as diagnostic and therapeutic device manufacturing -- cardiovascular, orthopedic, diagnostic imaging, in-vitro diagnostics, surgical/robotic, patient monitoring, ophthalmic, and dental categories -- deliberately excluding pharmaceutical manufacturing and healthcare services/delivery, which are covered as separate Navadhi mother reports. The market is forecast to grow from $581.1 billion in 2025 to $825.5 billion by 2031, a compound annual growth rate of approximately 6.0%, with growth rates gently accelerating year over year -- from 4.8% in 2026 to 6.7% in 2031 -- reflecting the compounding effect of structural demand drivers rather than any single-period event-driven surge.

M&A activity across the tracked player universe has been concentrated in two strategic themes: expanding surgical robotics capabilities and reinforcing connected-care platforms. Medtronic has continued to invest in its Hugo robotic-assisted surgery platform, targeting direct competition with Intuitive Surgical's da Vinci ecosystem, while simultaneously rationalizing its portfolio through selective divestitures, including the Patient Monitoring and Respiratory Interventions business separation completed in 2024. Stryker's Mako robotic orthopedic platform remains a core M&A-integration anchor, with the company pursuing bolt-on deals in neurosurgery and endoscopy to diversify beyond its core orthopedics franchise. Boston Scientific's exceptional 20.3% FY2025 growth has been materially supported by its acquisition strategy in electrophysiology and structural heart, while Insulet and Dexcom have deepened interoperability agreements with major consumer technology platforms, reflecting the industry's accelerating shift toward closed-loop, home-managed diabetes care systems.

Scope of Global Medical Devices Industry Strategic Research Report 2026-2031

• This report provides forecast data by value for the global medical devices industry, with 2025 as the base year and forecasting to 2031.
• This report provides segmentation by type (In Vitro Diagnostics, Cardiovascular Devices, Diagnostic Imaging, Surgical and Minimally Invasive/Robotic Devices, Patient Monitoring and Diabetes Care, Orthopedic Devices, Ophthalmic Devices) and by end-use setting (Hospitals, Diagnostic and Imaging Centers, Ambulatory Surgical Centers, Home Healthcare, Clinics and Physician Offices).
• This report provides region-wise and country-level forecast data across 5 regions and 16 countries.
• This report identifies key growth drivers and inhibitors, including population aging, rising chronic disease prevalence, and the accelerating commercial penetration of surgical robotics and connected diabetes care technologies.
• This report provides company profiles for the 25 leading medical device companies, each covering Company Overview, Key Products & Segments, Financial Performance, Business Strategy, SWOT Analysis, and Strategic Implications.
• This report provides Porter's Five Forces, PESTLE, and SWOT analysis.
• This report identifies key future trends through 2031.

Segment by Type

• In Vitro Diagnostics
• Cardiovascular Devices
• Diagnostic Imaging
• Surgical and Minimally Invasive/Robotic Devices
• Patient Monitoring and Diabetes Care
• Orthopedic Devices
• Ophthalmic Devices

Segment by Application

• Hospitals
• Diagnostic and Imaging Centers
• Ambulatory Surgical Centers
• Home Healthcare
• Clinics and Physician Offices

Segment by Region

• North America (United States, Canada, Rest of North America)
• Europe (Germany, France, United Kingdom, Italy, Rest of Europe)
• Asia-Pacific (China, Japan, South Korea, India, Australia, Rest of Asia Pacific)
• Latin America (Brazil, Mexico, Rest of Latin America)
• Middle East & Africa (Saudi Arabia, UAE, South Africa, Rest of Middle East and Africa)

Who Can Use the Global Medical Devices Industry Strategic Research Report?

This research report is ideal for people who wish to gain a thorough understanding of the medical devices market. Some of the intended users are:

• C-level executives and Company Directors in medical device manufacturing and distribution companies
• Investment managers, Financial professionals, and Healthcare/MedTech sector equity analysts
• Regulatory affairs and market access professionals tracking FDA, CE marking, and reimbursement policy
• Hospital and healthcare system procurement executives evaluating device technology and vendors
• Anyone operating in the global medical devices value chain